Cargando…
Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience
COVID-19 vaccines contain additives such as Polyethylenglycol-2000 (PEG2000; mRNA vaccines) or Polysorbat 80 (vector vaccines), which have been described previously as culprits for anaphylactic events. This retrospective study included 46 individuals, who were referred to Comprehensive Allergy Cente...
Autores principales: | Puxkandl, Viktoria, Bangerl, Theresa, Hanfstingl, Kathrin, Guenova, Emmanuella, Hoetzenecker, Wolfram, Altrichter, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120131/ https://www.ncbi.nlm.nih.gov/pubmed/35611049 http://dx.doi.org/10.1016/j.waojou.2022.100654 |
Ejemplares similares
-
Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab
por: Puxkandl, Viktoria, et al.
Publicado: (2023) -
Therapy resistant urticaria as a long-term symptom of an incomplete Schnitzler syndrome
por: Puxkandl, Viktoria, et al.
Publicado: (2023) -
Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
por: Hanfstingl, Kathrin, et al.
Publicado: (2018) -
Pseudolymphomatous Reaction to Red Tattoo Pigment
por: Saulite, Ieva, et al.
Publicado: (2018) -
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
por: Saulite, Ieva, et al.
Publicado: (2016)